Brokerages predict that Nutrien Ltd (NYSE:NTR) will report sales of $8.70 billion for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Nutrien’s earnings. The highest sales estimate is $8.97 billion and the lowest is $8.31 billion. Nutrien posted sales of $8.66 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 0.5%. The company is scheduled to report its next earnings results on Monday, August 3rd.
On average, analysts expect that Nutrien will report full-year sales of $20.40 billion for the current fiscal year, with estimates ranging from $19.49 billion to $21.79 billion. For the next financial year, analysts anticipate that the business will report sales of $21.14 billion, with estimates ranging from $20.00 billion to $23.00 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Nutrien.
Nutrien (NYSE:NTR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.08). Nutrien had a return on equity of 4.66% and a net margin of 4.49%. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $3.44 billion. During the same period last year, the company earned $0.20 earnings per share. The business’s quarterly revenue was up 12.6% compared to the same quarter last year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in NTR. Lindbrook Capital LLC lifted its holdings in shares of Nutrien by 227.1% in the first quarter. Lindbrook Capital LLC now owns 736 shares of the company’s stock valued at $25,000 after purchasing an additional 511 shares in the last quarter. Total Clarity Wealth Management Inc. purchased a new stake in shares of Nutrien in the fourth quarter valued at $26,000. Harwood Advisory Group LLC purchased a new stake in shares of Nutrien in the first quarter valued at $28,000. Americana Partners LLC purchased a new stake in shares of Nutrien in the fourth quarter valued at $29,000. Finally, CFM Wealth Partners LLC acquired a new position in shares of Nutrien in the first quarter worth $33,000. Institutional investors own 62.15% of the company’s stock.
NTR stock traded up $0.07 on Monday, reaching $32.65. The company’s stock had a trading volume of 1,914,115 shares, compared to its average volume of 1,893,677. Nutrien has a 52 week low of $23.85 and a 52 week high of $55.25. The company has a market capitalization of $18.82 billion, a P/E ratio of 20.80, a price-to-earnings-growth ratio of 2.50 and a beta of 0.87. The firm has a fifty day moving average of $34.83 and a two-hundred day moving average of $38.83. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.07 and a quick ratio of 0.59.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Monday, June 29th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 5.51%. Nutrien’s dividend payout ratio (DPR) is presently 82.95%.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Story: How interest rates affect municipal bond prices
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.